Showing 2,017 news articles about PrEP

Filters Content type: Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP science

Resistance Mutation Associated With PrEP Use in People Newly Diagnosed With HIV in New York City

Editor's pick
TheBodyPro
5 January 2024
PrEP science

On-Demand Versus Daily PrEP May Mitigate TDF’s Effect on Kidneys, Reports French Study

Editor's pick
TheBodyPro
28 December 2023
Resistance

History of PrEP Use Linked to M184I/V Mutation at HIV Diagnosis

Editor's pick
Infectious Disease Advisor
22 December 2023
PrEP policies & guidelines

US: Disparities in Prior Authorization Requirements May Reduce HIV PrEP Uptake, Access

Editor's pick
Infectious Disease Advisor
20 December 2023
Vaginal rings & topical PrEP

“On-demand” HIV prevention method for women being tested in second early phase trial

Editor's pick
EurekAlert!
7 December 2023
PrEP programmes & uptake

Beyond HIV Risk: PrEP Tied to Emotional & Social Benefits

Editor's pick
Physician's Weekly
6 December 2023
Vaginal rings & topical PrEP

How to protect women in the country most affected by AIDS: ‘I’m sick of begging my boyfriend to use condoms’

Editor's pick
El País
4 December 2023
Antibody-based prevention

Oral tenofovir/FTC increases clearance of bNAb VRC01: implications for future research

Editor's pick
i-Base
4 December 2023
PrEP programmes & uptake

Black Americans still struggle to access PrEP, a medication that could lower HIV rates in the community

Editor's pick
CNN
4 December 2023
Injectable & long-acting PrEP

Follow-Up Study Affirms Efficacy of Injectable Cabotegravir for PrEP, Though Questions Remain on Hypertension, Resistance

Editor's pick
TheBodyPro
4 December 2023
PrEP programmes & uptake

Study identifies barriers that limit young men at HIV risk from taking preventative drug

Editor's pick
EurekAlert!
1 December 2023
Injectable & long-acting PrEP

Long-Acting PrEP in Europe's Fight Against HIV

Editor's pick
Medscape (requires free registration)
1 December 2023
Vaginal rings & topical PrEP

Innovative HIV Prevention Product for Women that Promotes Choice – Dapivirine Vaginal Ring – Gains Momentum Across Africa

Editor's pick
Population Council
30 November 2023
PrEP policies & guidelines

UK: Government ‘exploring’ GP prescribing of HIV PrEP drug

Editor's pick
Pulse
30 November 2023
Injectable & long-acting PrEP

Progress continues to accelerate access to cabotegravir LA for PrEP in low and middle-income countries

Editor's pick
ViiV press release
30 November 2023
Vaginal rings & topical PrEP

South African company to start making vaginal rings that protect against HIV

Editor's pick
Associated Press
30 November 2023
PrEP policies & guidelines

Bending the curve: What a decade-long roll-out of the anti-HIV pill can teach the world

Editor's pick
Bhekisisa
28 November 2023
Pharmaceutical industry

Authorities warn that fake HIV drugs are found in Kenya despite a crackdown on counterfeits

Editor's pick
Associated Press
24 November 2023
Finance & funding

Slash the price by three-quarters — South African government on anti-HIV jab

Editor's pick
Bhekisisa
16 November 2023
Injectable & long-acting HIV treatment

In-depth: How do long-acting HIV treatments work?

Editor's pick
Spotlight
14 November 2023
Retention & linkage to care

Non-Compliance Isn't the Issue. Systemic Racism Prevents Access to HIV Prevention and Care

Editor's pick
TheBodyPro
13 November 2023
PrEP programmes & uptake

Research Explores Anxiety and Depression Trends in Australians Who Take PrEP

Editor's pick
TheBodyPro
10 November 2023
PrEP policies & guidelines

US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus

Editor's pick
KFF Health News
8 November 2023
PrEP policies & guidelines

US: The Task Force’s Latest PrEP Recommendation For HIV Is Just More Of The Same

Editor's pick
Health Affairs
6 November 2023